Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Receives $3.67 Consensus PT from Analysts

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report) has been given a consensus recommendation of “Hold” by the five brokerages that are presently covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average twelve-month price objective […]